Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities

Expert Rev Hematol. 2010 Jun;3(3):255-60. doi: 10.1586/ehm.10.22.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Anemia, Sickle Cell* / physiopathology
  • Anemia, Sickle Cell* / psychology
  • Anemia, Sickle Cell* / therapy
  • Antisickling Agents* / administration & dosage
  • Antisickling Agents* / adverse effects
  • Blood Transfusion
  • Child
  • Drug Monitoring / adverse effects*
  • Fear / psychology
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Hydroxyurea* / administration & dosage
  • Hydroxyurea* / adverse effects
  • Male
  • Patient Compliance / psychology
  • Patient Freedom of Choice Laws
  • Risk Assessment
  • Treatment Outcome
  • Young Adult

Substances

  • Antisickling Agents
  • Hydroxyurea